- 中文名
- (S)-4-(4-(苯并呋喃-5-基)苯基)-3-((1-(环丙烷羰基)吡咯烷-3-基)甲基)-1H-1,2,4-三唑-5(4H)-酮
- 英文名
- (S)-4-(4-(Benzofuran-5-yl)phenyl)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-1H-1,2,4-triazol-5(4H)-one
- CAS号
- 1332331-08-4
- 分子式
- C25H24N4O3
- 分子量
- 428.48
- 中文别名
- GSK2194069; 化合物T15429; 化合物GSK2194069; β-酮酰还原酶(KR)抑制剂GSK2194069; (S)-(3-((4-(4-(苯并呋喃-5-基)苯基)-5-羟基-4H-1,2,4-三唑-3-基)甲基)吡咯烷-1-基)(环丙基)甲酮
- 英文别名
- GSK 2194069; GSK-2194069; 4-[4-(1-benzofuran-5-yl)phenyl]-5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one; 4-(4-(1-benzofuran-5-yl)phenyl)-3-(((3S)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-1H-1,2,4-triazol-5-one; 4-[4-(1-benzofuran-5-yl)phenyl]-3-[[(3S)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]methyl]-1H-1,2,4-triazol-5-one; GTPL8605; orb1707243; (S)-4-(4-(benzofuran-5-yl)phenyl)-5-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one; 4-[4-(1-benzofuran-5-yl)phenyl]-3-{[(3S)-1-cyclopropanecarbonylpyrrolidin-3-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one; 4-[4-(5-Benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one; Fatty Acid Synthase Inhibitor II, GSK2194069
